MYC and neoplasm: The activation of MYC in Fh1-deficient cells, which was previously hypothesized [100], led to increased expression of the karyopherin subunit alpha 2 (Kpna2), a nuclear transporter involved in the nucleocytoplasmic transport of several tumour-associated factors [98, 101] (Fig. 2).